Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Sanfang Tu, MD PhD, Lan Deng, MD PhD, Rui Huang, MD PhD, Xuan Zhou, MD, Jilong Yang, MD, Weijun Zhou, MD PhD, Meifang Li, MD PhD, Chunyan Yue, MD, Shaojie Wu, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD

Blood (2018) 132 (Supplement 1): 4015.

https://doi.org/10.1182/blood-2018-99-118526

Published: 2018

Journal Articles

Safety and Efficacy of Blinatumomab in Patients with Central Nervous System (CNS) Disease: A Single Institution Experience

Mansour Alfayez, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Rita Assi, MD, Maria Khouri, Farhad Ravandi, MD, Shilpa Paul, PharmD, Caitlin R. Rausch, PharmD, Patrice Nasnas, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MDMSc, Tapan M. Kadia, MD, Naval G. Daver, MD, Guillermo Garcia-Manero, MD, Kiran Naqvi, MD MPH, Prithviraj Bose, MD, Susan M. O'Brien, MD, Jorge E. Cortes, MD, Elias J. Jabbour, MD

Blood (2018) 132 (Supplement 1): 2702.

https://doi.org/10.1182/blood-2018-99-117400

Published: 2018

Journal Articles

Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse

Xian Zhang, PhD, Xin-an Lu, Junfang Yang, MD, Fanyong LV, Min Xiong, Jianping Zhang, Xiaosu Zhou, Ting He, Peihua Lu

Blood (2018) 132 (Supplement 1): 280.

https://doi.org/10.1182/blood-2018-99-115642

Published: 2018

Journal Articles

CD20-Tcb (RG6026), a Novel "2:1" Format T-Cell-Engaging Bispecific Antibody, Induces Complete Remissions in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: Preliminary Results from a Phase I First in Human Trial

Martin Hutchings, MD PhD, Gloria Iacoboni, MD, Franck Morschhauser, MD, Fritz Offner, MD, Anna Sureda, MD, Gilles Andre Salles, MD PhD, Carmelo Carlo-Stella, MD, Joaquin Martinez Lopez, MD, Denise Thomas, BS, Peter N Morcos, PhD, Betsy Quackenbush, MD, Cristiano Ferlini, MD, Marina Bacac, PhD, Ann-Marie E. Broeske, PhD, Natalie Dimier, PhD, Tom Moore, MD, Martin Weisser, MD, Michael Dickinson, MD

Blood (2018) 132 (Supplement 1): 226.

https://doi.org/10.1182/blood-2018-99-110207

Published: 2018

Journal Articles

Incidence and Predictors of Late-Occurring Central Nervous System Complications in Allogeneic Hematopoietic Cell Transplant Survivors

Aida Siyahian, Heeyoung Kim, MS, Jennifer Berano Teh, Howard Chang, Liezl Atencio, Alicia Gonzales, F. Lennie Wong, PhD, Ryotaro Nakamura, MD, Canlan Sun, PhD, Saro Armenian, DO, MPH

Blood (2016) 128 (22): 5799.

https://doi.org/10.1182/blood.V128.22.5799.5799

Published: 2016

Journal Articles

Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem-Cell Transplant (ASCT) without Post-ASCT Maintenance, in Hodgkins Lymphoma Patients at High Risk of Post-Transplant Recurrence Comparison with a Concurrent Matched Cohort Treated with BEAM

Blood (2015) 126 (23): 1980.

https://doi.org/10.1182/blood.V126.23.1980.1980

Published: 2015

Journal Articles

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Gunilla Enblad, MDPhD, Hannah Karlsson, PhD, Kristina Wikstrom, PhD, Magnus Essand, PhD, Barbara Savoldo, MD PhD, Malcolm K. Brenner, MD PhD, Gianpietro Dotti, MD, Helene Hallbook, MDPhD, Martin Hoglund, MD PhD, Hans Hagberg, MD PhD, Angelica Loskog, PhD

Blood (2015) 126 (23): 1534.

https://doi.org/10.1182/blood.V126.23.1534.1534

Published: 2015

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation with Treosulfan-Based Conditioning Regimen for Acute Leukemia Relapsing after Initial Allogeneic Transplantation

Jacopo Peccatori, MD, Lara Crucitti, MD, Raffaella Greco, MD, Maria Teresa Lupo Stanghellini, MD, Luca Vago, MD PhD, Nicoletta Cieri, MD PhD, Corrado Zuanelli Brambilla, MD, Fabio Giglio, MD, Mara Morelli, MD, Andrea Assanelli, MD, Magda Marcatti, MD, Matteo G Carrabba, MD, Chiara Bonini, MD, Massimo Bernardi, MD, Fabio Ciceri, MD

Blood (2014) 124 (21): 3956.

https://doi.org/10.1182/blood.V124.21.3956.3956

Published: 2014

Journal Articles

Phase II Randomized Trial Of Radiation-Free Central Nervous System (CNS) Prophylaxis Comparing Intrathecal Triple Therapy With Liposomal Cytarabine (DepoCyte ® ) In Adult Acute Lymphoblastic Leukemia (ALL)

Blood (2013) 122 (21): 3901.

https://doi.org/10.1182/blood.V122.21.3901.3901

Published: 2013

Journal Articles

Itraconazol Inhibits the P-Glycoprotein Pump and Increases Vincristine Induced Toxicity in Patients with Acute Lymphoblastic Leukemia Carrying a Genetic Variant of the MDR1 Gene

D. Maroeska W.M. te Loo, MD, PhD, Melanie Hagleitner, Peter M. Hoogerbrugge, MD, PhD, Rosalinde Masareeuw, Marieke Coenen

Blood (2011) 118 (21): 231.

https://doi.org/10.1182/blood.V118.21.231.231

Published: 2011

Journal Articles

A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma

Tomer M Mark, MD, MSc, Whitney Reid, Ruben Niesvizky, MD, Usama Gergis, MD, Roger N Pearse, MD, PhD, Sebastian Mayer, MD, Morton Coleman, MD, Eric J Feldman, MD, Tsiporah B. Shore, MD

Blood (2011) 118 (21): 2042.

https://doi.org/10.1182/blood.V118.21.2042.2042

Published: 2011

Journal Articles

Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia (ALL) Treated with Modified Augmented Berlin-Frankfurt-Muenster (ABFM) Therapy

Michael E. Rytting, MD, Deborah A. Thomas, MD, Elias Jabbour, Anna R.K. Franklin, M.D., Gautam Borthakur, Stefan Faderl, MD, Kurt Schroeder, RN, Farhad Ravandi, MD, Rebecca Garris, BSc, Susan o'Brien, Hagop M. Kantarjian

Blood (2011) 118 (21): 1527.

https://doi.org/10.1182/blood.V118.21.1527.1527

Published: 2011

Journal Articles

Adolescent and Young Adult Patients Treated with Modified Augmented Berlin-Frankfurt-Muenster Therapy

Michael E. Rytting, MD, Hagop M. Kantarjian, MD, Deborah A Thomas, MD, Elias Jabbour, MD, Anna Franklin, M.D., Farhad Ravandi, MD, Stefan Faderl, MD, Rebecca Garris, BA, Tapan Kadia, MD, Kurt Schroeder, RN, Susan O'Brien, MD

Blood (2010) 116 (21): 3250.

https://doi.org/10.1182/blood.V116.21.3250.3250

Published: 2010

Journal Articles

Guillain-Barre Syndrome Following Azacitidine for Treatment of Myelodysplastic Syndrome.

Phoebe E. Harvey, MD, Mary Lynn R. Nierodzik, MD, Jennifer Wu, MD

Blood (2009) 114 (22): 4861.

https://doi.org/10.1182/blood.V114.22.4861.4861

Published: 2009

Journal Articles

Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Patients with High-Risk AML in First CR: The ALFA-0702 Pilot Study.

Xavier Thomas, Ida Lobe, Emmanuel Raffoux, Nicolas Boissel, Quoc-Hung Le, Franck Nicolini, Adrienne de Labarthe, Sandrine Hayette, Jean-Michel Cayuela, Hervé Dombret

Blood (2008) 112 (11): 1934.

https://doi.org/10.1182/blood.V112.11.1934.1934

Published: 2008

Journal Articles

Epigenetic Therapy with 5-Azacitidine, Valproic Acid, and ATRA in Patients with High-Risk AML or MDS: Results of the French VIVEDEP Phase II Study

Emmanuel Raffoux, Adrienne de Labarthe, Audrey Cras, Christian Recher, Pascal Turlure, Jean-Pierre Marolleau, Oumedaly Reman, Claude Gardin, Sebastien Maury, Philippe Rousselot, Jean-Valère Malfuson, Odile Maarek, Laurent Degos, Christine Chomienne, Hervé Dombret

Blood (2008) 112 (11): 763.

https://doi.org/10.1182/blood.V112.11.763.763

Published: 2008

Journal Articles

The Effectiveness of Once-Daily Intravenous Busulfan as Conditioning for Hematopoietic Stem Cell Transplantation in Children with Acute Myelogenous Leukemia.

Seong Shik Park, MD, Seong Heon Kim, MD., Young Tak Lim, MD

Blood (2007) 110 (11): 4948.

https://doi.org/10.1182/blood.V110.11.4948.4948

Published: 2007

Journal Articles

Brain Sparing Conditioning Regimen and Umbilical Cord Blood Transplantation for Inherited High Risk Neurologic Metabolic Diseases.

Jakub Tolar, MD, PhD, Pamala Jacobson, Ph.D., Lawrence Charnas, M.D., Ph.D., Paul J. Orchard, M.D.

Blood (2007) 110 (11): 3009.

https://doi.org/10.1182/blood.V110.11.3009.3009

Published: 2007

Journal Articles

Isolated Brain Parenchyma Relapse of Non-Hodgkin’s Lymphoma (NHL): A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Nancy D. Doolittle, PhD, Lauren Abrey, MD, Tamara Shenkier, Tali Siegal, Jacoline Bromberg, Edward Neuwelt, Carole Soussain, Patrick Johnston, Gerald Illerhaus, David Schiff, Tracy Batchelor, Silvia Montoto, Emanuele Zucca, Dale Kraemer

Blood (2006) 108 (11): 2026.

https://doi.org/10.1182/blood.V108.11.2026.2026

Published: 2006

NARROW

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Safety and Efficacy of Blinatumomab in Patients with Central Nervous System (CNS) Disease: A Single Institution Experience

Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse

CD20-Tcb (RG6026), a Novel "2:1" Format T-Cell-Engaging Bispecific Antibody, Induces Complete Remissions in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: Preliminary Results from a Phase I First in Human Trial

Incidence and Predictors of Late-Occurring Central Nervous System Complications in Allogeneic Hematopoietic Cell Transplant Survivors

Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem-Cell Transplant (ASCT) without Post-ASCT Maintenance, in Hodgkins Lymphoma Patients at High Risk of Post-Transplant Recurrence Comparison with a Concurrent Matched Cohort Treated with BEAM

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Haploidentical Hematopoietic Stem Cell Transplantation with Treosulfan-Based Conditioning Regimen for Acute Leukemia Relapsing after Initial Allogeneic Transplantation

Phase II Randomized Trial Of Radiation-Free Central Nervous System (CNS) Prophylaxis Comparing Intrathecal Triple Therapy With Liposomal Cytarabine (DepoCyte ® ) In Adult Acute Lymphoblastic Leukemia (ALL)

Itraconazol Inhibits the P-Glycoprotein Pump and Increases Vincristine Induced Toxicity in Patients with Acute Lymphoblastic Leukemia Carrying a Genetic Variant of the MDR1 Gene

A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma

Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia (ALL) Treated with Modified Augmented Berlin-Frankfurt-Muenster (ABFM) Therapy

Adolescent and Young Adult Patients Treated with Modified Augmented Berlin-Frankfurt-Muenster Therapy

Guillain-Barre Syndrome Following Azacitidine for Treatment of Myelodysplastic Syndrome.

Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Patients with High-Risk AML in First CR: The ALFA-0702 Pilot Study.

Epigenetic Therapy with 5-Azacitidine, Valproic Acid, and ATRA in Patients with High-Risk AML or MDS: Results of the French VIVEDEP Phase II Study

The Effectiveness of Once-Daily Intravenous Busulfan as Conditioning for Hematopoietic Stem Cell Transplantation in Children with Acute Myelogenous Leukemia.

Brain Sparing Conditioning Regimen and Umbilical Cord Blood Transplantation for Inherited High Risk Neurologic Metabolic Diseases.

Isolated Brain Parenchyma Relapse of Non-Hodgkin’s Lymphoma (NHL): A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only